Most Alzheimer's genetics research focuses on the risky APOE4 gene. A new study turns to its protective cousin — APOE2 — and finds a clue to why some brains age more gracefully.
Scientists at the Buck Institute for Research on Aging, writing in Aging Cell, report that neurons carrying APOE2 are better at preventing and repairing DNA damage, and more resistant to cellular senescence — the worn-out, damaged state that's tied to neurodegeneration.
How they tested it
The team used human neurons grown from stem cells, engineered to differ only at the APOE gene, so any difference could be traced to APOE alone. They tested both inhibitory (GABAergic) and excitatory (glutamatergic) neurons, and backed the work up with brain tissue from mice carrying the human APOE2, APOE3, or APOE4 genes.
APOE2 neurons showed significantly fewer DNA strand breaks and lower markers of senescence after stress than the other variants. For context, APOE4 is the single strongest genetic risk factor for late-onset Alzheimer's.
“APOE2 neurons are better at preventing and repairing DNA damage,” said senior author Lisa M. Ellerby, adding that the findings “point to entirely new therapeutic directions.”
Why it matters
If APOE2's protection comes from stronger DNA repair, drugs that mimic that effect could open a new avenue for Alzheimer's prevention — one focused on keeping neurons' DNA healthy rather than clearing plaques. This is early laboratory science, not a treatment, but it reframes a well-known risk gene into a potential blueprint for protection.